Preparation method and use method of simvastatin-carrying ultrasonic targeting microbubbles

A technology of simvastatin and targeted microbubbles, which is applied to medical preparations with no active ingredients, medical preparations containing active ingredients, and pharmaceutical formulas, etc., can solve the problems of no uniform standards for ultrasound intensity and time, and achieve improved The effect of drug action time, reducing damage, and stabilizing properties

Active Publication Date: 2021-04-20
NANJING FIRST HOSPITAL
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] Aiming at the problem that ultrasonic microbubble targeted rupture technology combined with statins is not applied to the treatment of arthritis, ultrasonic targeted statins are used in the treatment of osteoarthritis, an

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method and use method of simvastatin-carrying ultrasonic targeting microbubbles
  • Preparation method and use method of simvastatin-carrying ultrasonic targeting microbubbles
  • Preparation method and use method of simvastatin-carrying ultrasonic targeting microbubbles

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] A preparation method of ultrasound-targeted microbubbles carrying simvastatin, the steps are as follows:

[0029] (1), dissolve simvastatin in tetrahydrofuran and dissolve, then add physiological saline and dilute into 0.05mg / mL simvastatin solution;

[0030] (2), adding trimethyl chitosan in the simvastatin solution, the final concentration is 1-3%;

[0031] (3), add sodium tripolyphosphate in the mixture that step (2) obtains, then-OH of simvastatin structure, trimethyl chitosan structure-NH2, the-OH on sodium tripolyphosphate structure, through Lorentz forces combine to form a stable spatial network, and the resulting mixture is a fluorescent emulsion. The particle size is about 500nm through electron microscope detection.

[0032] (4) Freeze-dry the suspension obtained in step (3), add the reconstitution agent sodium alginate to dissolve completely, transfer the obtained liquid to a vial filled with C3F8 gas, and vibrate the vial with a mechanical oscillator to for...

Embodiment 2

[0034] Embodiment 2 compares the impact of different ultrasonic targeting conditions on the rupture of simvastatin microbubbles;

[0035] 1) Experimental process:

[0036]Take 12 healthy New Zealand white rabbits, all of which are adult males. Three of them are randomly selected as a group, and they are divided into 4 groups. 200 μL of simvastatin microbubbles are injected into the right knee joint respectively. 1, 2 W / cm outside the right knee joint cavity 2 Ultrasonic intensity and irradiation time of 2 and 5 minutes were irradiated, and the optimal ultrasonic parameters were screened according to the ultrasonic images to observe the rupture of simvastatin microbubbles.

[0037] 2) Experimental results:

[0038] figure 2 In order to compare the effect of simple statin drug therapy and ultrasonic targeted statin drug therapy on OA cartilage, the rupture of simvastatin microbubbles under different ultrasonic parameters in the ultrasonic images: non-cavitated microbubbles s...

Embodiment 3

[0039] Example 3 Comparison of the effects of simple statin drug therapy and ultrasound-targeted simvastatin microbubble therapy on OA cartilage

[0040] 1. Experimental process:

[0041] (1) Grouping: The OA experimental rabbits were randomly divided into 3 groups, 6 in each group, and the pathological changes of the knee articular cartilage surface in each group were compared by Safranin O Fast Green staining.

[0042] Group 1# was given simvastatin (PSV): 0.1 mg / mL simvastatin solution was injected into the right knee joint cavity

[0043] Group 2# ultrasound-targeted simvastatin microbubbles group (USV group); USV group was injected with 0.1mg / mL simvastatin microbubbles into the right knee joint cavity, and at the same time 1MHz, 2W / cm 2 , the on-off ratio was 20%, and the irradiation time was 5 minutes to induce microbubble rupture, and 200 μL was injected into the knee joint cavity of each rabbit. At the same time, different dosage groups (0.1, 0.2, 0.3, 0.4, 0.5mg / ml...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
The average particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention relates to a preparation method of simvastatin-carrying ultrasonic targeting microbubbles. The preparation method comprises the following steps of dissolving simvastatin in tetrahydrofuran, and diluting with normal saline until the concentration is 0.01-0.1 mg/mL; adding trimethyl chitosan and sodium tripolyphosphate, compounding to form a stable spatial network result, obtaining a suspension, freeze-drying and re-dissolving the suspension, transferring the obtained liquid into a small bottle filled with C3F8 gas, oscillating the small bottle by using a mechanical oscillator to form 0.05 mg/mL simvastatin microbubbles, filling high-pressure C3F8 gas into the remaining space of the small bottle, sealing and storing, and refrigerating for later use; and feeding simvastatin microbubbles into a knee joint cavity, applying ultrasonic waves at the same time, controlling the ultrasonic intensity and time, wherein targeted induction microbubble rupture reaches the maximum proportion. The administration targeting property is strong, the administration period is shortened, the side effect of long-term administration is reduced, and the administration dosage is reduced.

Description

technical field [0001] The invention belongs to the field of new drug dosage forms and applications thereof, and in particular relates to an ultrasound-targeted microbubble carrying simvastatin and its application for treating osteoarthritis. Background technique [0002] Arthritis (osteoarthritis, OA) is a common clinical chronic, articular cartilage degenerative disease, the main symptoms are joint pain, stiffness and dysfunction. In my country, OA mainly occurs in middle-aged and elderly people, and the incidence rate increases with age. Epidemiological surveys show that 90% of women and 80% of men over 65 years old suffer from OA, and the prevalence of knee OA exceeds 10%. %, is the leading cause of physical disability in the elderly population. With the increase of sports trauma and life expectancy, the incidence of OA is increasing year by year, and the average age of OA tends to be younger. With the progress of OA-related epidemiology and molecular biology research, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K41/00A61K31/366A61K47/52A61K47/61A61P19/02A61P29/00
Inventor 李雪萍夏鹏陈安亮王馨伟程凯林强俞长君杨婷高明霞王晓菊王琪宋九龙
Owner NANJING FIRST HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap